U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...
Our experts share their tips on how to decide which type of vacuum—upright, canister, handheld, or robotic—to buyTo keep your floors their cleanest, start with a full-sized canister or upright ...
Hosted on MSN21d
The 5 Best Vacuums for Carpeted Stairs and Steps in 2025, According to Cleaning ProsThis Shark Vertex Pro Cordless Vacuum might be the best ... And to make things even easier, it’s simple to convert into a handheld machine by placing one of the attachments on the canister.
The main advantages of owning a cordless stick vacuum are easy portability and storage. But what you trade for the convenience is battery life and runtime. Most cordless stick vacuums run for up to 15 ...
Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...
The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...
UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...
See the 10 stocks » What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results